A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia

Conditions: Functional Dyspepsia

Sex: All

Ages: 19 Years – 75 Years

Healthy volunteers: No

Phase: PHASE4

Enrollment: 300

Sponsor: Dong-A ST Co., Ltd.

Summary

This study will evaluate the efficacy and safety of DA-9701 in patients with functional dyspepsia

Eligibility Criteria

Main Inclusion Criteria: * Men or women aged 19 to 75 years, inclusive * Subjects diagnosed with functional dyspepsia according to the Rome IV criteria * Subjects with at least three symptoms rated as moderate or severe on the Gastrointestinal Symptom Score(GIS) * Subjects who voluntarily signed a consent form Main Exclusion Criteria: * Subjects with a history of organic diseases that could cause dyspepsia * Subjects with hypersensitivity to investigational drugs and similar drugs * Pregnant or breastfeeding women

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07686679). StuddyBuddy aggregates publicly available trial information.